Correction: Retinopathy of prematurity in Rwanda: a prospective multi-centre study following introduction of screening and treatment services.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.In the original Article, Erwin Van Kerschaver was erroneously attributed an affiliation. This has been corrected in the XML,HTML and PDF versions of this Article.

Retinopathy of prematurity in Rwanda: a prospective multi-centre study following introduction of screening and treatment services.

Objectives: To investigate risk factors for retinopathy of prematurity (ROP) in a newly established ROP screening and management programme in Rwanda, Africa.

Methods: In this multi-centre prospective study 795/2222 (36%) babies fulfilled the inclusion criteria (gestational age (GA) < 35 weeks or birth weight (BW) < 1800 g or unstable clinical course), 424 (53%) of whom were screened for ROP. 270 died before the first screening.

Assessment of haematological parameters in HIV-infected and uninfected Rwandan women: a cross-sectional study.

Objectives: Although haematological abnormalities are common manifestations of HIV infection, few studies on haematological parameters in HIV-infected persons have been undertaken in sub-Saharan Africa. The authors assessed factors associated with haematological parameters in HIV-infected antiretroviral-naïve and HIV-uninfected Rwandan women.

Study Design: Cross-sectional analysis of a longitudinal cohort.

Adherence to highly active antiretroviral treatment in HIV-infected Rwandan women.

Background: Scale-up of highly active antiretroviral treatment therapy (HAART) programs in Rwanda has been highly successful but data on adherence is limited. We examined HAART adherence in a large cohort of HIV+ Rwandan women.

Methods: The Rwanda Women's Interassociation Study Assessment (RWISA) was a prospective cohort study that assessed effectiveness and toxicity of ART.